Sabon Maganin Migraine Na Injectable Yana Aiki Cikin Kwanaki, Yana Bada Maganin Ciwon Kai Kafin Ya Faru
Sabon Maganin Migraine Na Injectable Yana Aiki Cikin Kwanaki, Yana Bada Maganin Ciwon Kai Kafin Ya Faru
Anonim

Babu magani ga migraines, kuma yawancin jiyya na rigakafi suna ɗaukar ɗan lokaci kaɗan don yin tasiri. Saboda ciwon kai na iya zama mai rauni da kuma zubar da jini, masu bincike sun yi aiki don samar da maganin da zai iya hana wani ciwon kai a cikin 'yan kwanaki, yana dakatar da shi kafin ya bayyana. Yanzu, masu bincike a Teva Pharmaceuticals a Frazer, Penn. sun yi imanin sun samar da wani maganin allura wanda ke aiki a cikin kwanaki, yana rage yawan lokacin da ake ɗauka don maganin ƙaura. Masu binciken sun buga sakamakon bincikensu a mujallar Neurology.

ciwon kai

A cikin binciken, masu binciken sun bincika mahalarta 261 waɗanda suka fuskanci ƙaura na tsawon shekaru 18 kafin su fara magani. A cikin tsawon wata guda, suna da ciwon kai har zuwa sa'o'i 162 - suna yada tsawon kwanaki 22 na ciwon kai. Ga irin waɗannan mutane, migraines na iya cirewa daga rayuwa ta al'ada, lafiya. Magungunan da ake tambaya, wanda aka sani da TEV-48125, yana aiki azaman antibody wanda ke toshe wani peptide mai alaƙa da ciwon ƙaura.

A cikin watanni uku, mahalarta 87 sun sami allurar ƙarancin allura na wata-wata, kuma 89 sun sami harbin placebo. Wasu 85 sun yi harbin mai girma. An ba su duka littafin diary na lantarki wanda a cikinsa suka rubuta ciwon kai. Ya bayyana cewa bayan mako guda kawai, matsakaicin adadin sa'o'i na ƙaura ya ragu da sa'o'i 2.9 ga wadanda ke shan placebo, yayin da mutanen da ke shan magungunan ƙananan ƙwayoyi sun ga raguwar sa'o'i 9.1 a matsakaicin sa'o'i na zafi. Mutanen da suka sha maganin mai yawa, a halin yanzu, sun ga har zuwa 11.4 ƴan sa'o'i na ciwon kai. Yawancin magungunan miyagun ƙwayoyi sun fara aiki a cikin 'yan kwanaki na mahalarta shan ta.

"Maganin ciwon kai na yau da kullum yana shafar kusan 1 bisa dari na dukan manya, duk da haka kasa da 5 bisa dari na mutanen da suka sami daidaitattun ganewar asali da kuma maganin da ya dace," in ji Dokta Marcelo Bigal na Teva Pharmaceuticals, marubucin binciken, a cikin wata sanarwa. "Mafi yawan mutanen da ke karbar maganin rigakafi don ciwon kai na kullum sun daina amfani da su, kuma dalili daya na hakan shi ne kwayoyi na iya daukar lokaci mai tsawo don yin tasiri."

Mutanen da suka cancanci maganin rigakafi gabaɗaya dole ne su fuskanci hare-haren ƙaura huɗu a kowane wata, ko kuma idan migraines ya wuce sa'o'i 12. Har ila yau, marasa lafiya na iya yin la'akari da magungunan rigakafi idan kwayoyin da ke rage ciwo na yau da kullum ba su yi aiki ba. Magungunan rigakafi na yau da kullun sun haɗa da wasu magungunan zuciya kamar beta blockers - waɗanda galibi ana amfani da su don magance cutar hawan jini ko cututtukan jijiya - da kuma maganin damuwa, abin sha'awa. An samo wasu magungunan kashe kwayoyin cuta don rage migraines. Wasu na iya haɗawa da magungunan rigakafin kamawa da Botox.

Masu bincike na sabon binciken za su buƙaci yin ƙarin bincike kafin a iya amfani da maganin a asibiti. "Idan za a iya tabbatar da waɗannan sakamakon tare da manyan karatu, wannan zai iya zama mai ban sha'awa ga mutanen da ke fama da ƙaura," in ji Bigal a cikin sanarwar manema labarai.

Shahararren taken